BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28105093)

  • 21. Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs.
    Chen X; Chen J; Xu D; Zhao S; Song H; Peng Y
    BMC Musculoskelet Disord; 2017 Oct; 18(1):423. PubMed ID: 29073887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of osteoclastogenesis by adipogenic conversion of bone marrow-derived mesenchymal stem cells.
    Mori K; Suzuki K; Hozumi A; Goto H; Tomita M; Koseki H; Yamashita S; Osaki M
    Biomed Res; 2014; 35(2):153-9. PubMed ID: 24759183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGFβ-induced switch from adipogenic to osteogenic differentiation of human mesenchymal stem cells: identification of drug targets for prevention of fat cell differentiation.
    van Zoelen EJ; Duarte I; Hendriks JM; van der Woning SP
    Stem Cell Res Ther; 2016 Aug; 7(1):123. PubMed ID: 27562730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis.
    Zhang Y; Su J; Wu S; Teng Y; Yin Z; Guo Y; Li J; Li K; Yao L; Li X
    Sci Signal; 2015 Mar; 8(369):ra31. PubMed ID: 25805889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-Term Hypoxia Accelerates Bone Loss in Ovariectomized Rats by Suppressing Osteoblastogenesis but Enhancing Osteoclastogenesis.
    Wang G; Wang J; Sun D; Xin J; Wang L; Huang D; Wu W; Xian CJ
    Med Sci Monit; 2016 Aug; 22():2962-71. PubMed ID: 27550548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERRalpha regulates osteoblastic and adipogenic differentiation of mouse bone marrow mesenchymal stem cells.
    Rajalin AM; Pollock H; Aarnisalo P
    Biochem Biophys Res Commun; 2010 May; 396(2):477-82. PubMed ID: 20417614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation.
    Jin J; Wang L; Wang XK; Lai PL; Huang MJ; Jin DD; Zhong ZM; Chen JT; Bai XC
    J Surg Res; 2013 Mar; 180(1):e21-9. PubMed ID: 22487394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect and mechanism of psoralidin on promoting osteogenesis and inhibiting adipogenesis.
    Cao HJ; Li CR; Wang LY; Ziadlou R; Grad S; Zhang Y; Cheng Y; Lai YX; Yao XS; Alini M; Qin L; Wang XL
    Phytomedicine; 2019 Aug; 61():152860. PubMed ID: 31048126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures.
    Justesen J; Stenderup K; Eriksen EF; Kassem M
    Calcif Tissue Int; 2002 Jul; 71(1):36-44. PubMed ID: 12200657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutamate preferentially suppresses osteoblastogenesis than adipogenesis through the cystine/glutamate antiporter in mesenchymal stem cells.
    Takarada-Iemata M; Takarada T; Nakamura Y; Nakatani E; Hori O; Yoneda Y
    J Cell Physiol; 2011 Mar; 226(3):652-65. PubMed ID: 20717926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of fetal hemoglobin expression during hematopoietic stem cell development and its importance in bone metabolism and osteoporosis.
    Kos O; Alexander C; Brandenburg K; Chen Z; Heini A; Heumann D; Khatri I; Mach JP; Rietschel ET; Terskikh A; Ulmer AJ; Waelli T; Yu K; Zähringer U; Gorczynski RM
    Int Immunopharmacol; 2018 Apr; 57():112-120. PubMed ID: 29477972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis.
    Elabd C; Basillais A; Beaupied H; Breuil V; Wagner N; Scheideler M; Zaragosi LE; Massiéra F; Lemichez E; Trajanoski Z; Carle G; Euller-Ziegler L; Ailhaud G; Benhamou CL; Dani C; Amri EZ
    Stem Cells; 2008 Sep; 26(9):2399-407. PubMed ID: 18583541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual effect of WIN-34B on osteogenesis and osteoclastogenesis in cytokine-induced mesenchymal stem cells and bone marrow cells.
    Seo BK; Ryu HK; Park YC; Huh JE; Baek YH
    J Ethnopharmacol; 2016 Dec; 193():227-236. PubMed ID: 27401292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
    Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH
    J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid Hormone Shifts Cell Fate of a Leptin Receptor-Marked Stromal Population from Adipogenic to Osteoblastic Lineage.
    Yang M; Arai A; Udagawa N; Zhao L; Nishida D; Murakami K; Hiraga T; Takao-Kawabata R; Matsuo K; Komori T; Kobayashi Y; Takahashi N; Isogai Y; Ishizuya T; Yamaguchi A; Mizoguchi T
    J Bone Miner Res; 2019 Oct; 34(10):1952-1963. PubMed ID: 31173642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasticizer di(2-ethylhexyl)phthalate interferes with osteoblastogenesis and adipogenesis in a mouse model.
    Chiu CY; Sun SC; Chiang CK; Wang CC; Chan DC; Chen HJ; Liu SH; Yang RS
    J Orthop Res; 2018 Apr; 36(4):1124-1134. PubMed ID: 28921615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoblastic Wnts differentially regulate bone remodeling and the maintenance of bone marrow mesenchymal stem cells.
    Wan Y; Lu C; Cao J; Zhou R; Yao Y; Yu J; Zhang L; Zhao H; Li H; Zhao J; Zhu X; He L; Liu Y; Yao Z; Yang X; Guo X
    Bone; 2013 Jul; 55(1):258-67. PubMed ID: 23334081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of basic fibroblast growth factor and a prostaglandin E2 receptor subtype 4 agonist on osteoblastogenesis and adipogenesis in aged ovariectomized rats.
    Aguirre JI; Leal ME; Rivera MF; Vanegas SM; Jorgensen M; Wronski TJ
    J Bone Miner Res; 2007 Jun; 22(6):877-88. PubMed ID: 17352655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling.
    Saidak Z; Haÿ E; Marty C; Barbara A; Marie PJ
    Aging Cell; 2012 Jun; 11(3):467-74. PubMed ID: 22321691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.